6.
Jess T, Loftus Jr E, Harmsen W, Zinsmeister A, Tremaine W, Melton 3rd L
. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut. 2006; 55(9):1248-54.
PMC: 1860022.
DOI: 10.1136/gut.2005.079350.
View
7.
Schrumpf E, Boberg K
. Primary sclerosing cholangitis: challenges of a new millenium. Dig Liver Dis. 2001; 32(9):753-5.
DOI: 10.1016/s1590-8658(00)80350-3.
View
8.
Broome U, Bergquist A
. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006; 26(1):31-41.
DOI: 10.1055/s-2006-933561.
View
9.
Joo M, Abreu-E-Lima P, Farraye F, Smith T, Swaroop P, Gardner L
. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009; 33(6):854-62.
DOI: 10.1097/PAS.0b013e318196d018.
View
10.
Loftus Jr E, Harewood G, Loftus C, Tremaine W, Harmsen W, Zinsmeister A
. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2004; 54(1):91-6.
PMC: 1774346.
DOI: 10.1136/gut.2004.046615.
View
11.
Pollheimer M, Halilbasic E, Fickert P, Trauner M
. Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol. 2011; 25(6):727-39.
PMC: 3236286.
DOI: 10.1016/j.bpg.2011.10.009.
View
12.
Shepherd H, Selby W, Chapman R, Nolan D, Barbatis C, Mcgee J
. Ulcerative colitis and persistent liver dysfunction. Q J Med. 1983; 52(208):503-13.
View
13.
Fausa O, Schrumpf E, Elgjo K
. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis. 1991; 11(1):31-9.
DOI: 10.1055/s-2008-1040420.
View
14.
Moayyeri A, Ebrahimi Daryani N, Bahrami H, Haghpanah B, Nayyer-Habibi A, Sadatsafavi M
. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol. 2005; 20(3):366-70.
DOI: 10.1111/j.1440-1746.2005.03727.x.
View
15.
Angulo P, Peter J, Gershwin M, DeSotel C, Shoenfeld Y, Ahmed A
. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol. 2000; 32(2):182-7.
DOI: 10.1016/s0168-8278(00)80061-6.
View
16.
Farmer R, Easley K, RANKIN G
. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci. 1993; 38(6):1137-46.
DOI: 10.1007/BF01295733.
View
17.
Angulo P, Lindor K
. Primary sclerosing cholangitis. Hepatology. 1999; 30(1):325-32.
DOI: 10.1002/hep.510300101.
View
18.
Lundqvist K, Broome U
. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997; 40(4):451-6.
DOI: 10.1007/BF02258391.
View
19.
Smith M, LOE R
. SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES. Am J Surg. 1965; 110:239-46.
DOI: 10.1016/0002-9610(65)90018-8.
View
20.
Jess T, Gamborg M, Munkholm P, Sorensen T
. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2006; 102(3):609-17.
DOI: 10.1111/j.1572-0241.2006.01000.x.
View